Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Delobel

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Antimicrobial Chemotherapy|June 17, 2011
Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropismStéphanie Raymond, Patricia Recordon-Pinson, Adrien Saliou, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 20, 2022
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimabCamille Vellas, Pauline Trémeaux, Arnaud Del Bello, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 19, 2021
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispeciesCamille Vellas, Arnaud Del Bello, Alexa Debard, et al.
Cancers|January 21, 2022
Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Cyrille Delpierre, et al.
British Journal of Clinical Pharmacology|November 14, 2018
Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT studyMinh P Lê, Marie-Laure Chaix, François Raffi, et al.
AIDS (London, England)|July 18, 2022
Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIVStella Rousset, Mathilde Zenou, Aurélie Saunier, et al.
Journal of the International AIDS Society|April 26, 2020
Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohortSophie Novelli, Pierre Delobel, Olivier Bouchaud, et al.
Medicine|September 16, 2016
Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort StudyPaul de Boissieu, Moustapha Dramé, François Raffi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2012
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 studyLise Cuzin, Selma Trabelsi, Pierre Delobel, et al.
The Journal of Infectious Diseases|November 19, 2024
Compartmentalized Human Immunodeficiency Virus Type 1 Reservoir in Intestinal Monocytes/Macrophages on Antiretroviral TherapyCamille Vellas, Dorine Martres, Mary Requena, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|June 17, 2011
Improved V3 genotyping with duplicate PCR amplification for determining HIV-1 tropismStéphanie Raymond, Patricia Recordon-Pinson, Adrien Saliou, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 20, 2022
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimabCamille Vellas, Pauline Trémeaux, Arnaud Del Bello, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 19, 2021
Influence of treatment with neutralizing monoclonal antibodies on the SARS-CoV-2 nasopharyngeal load and quasispeciesCamille Vellas, Arnaud Del Bello, Alexa Debard, et al.
Cancers|January 21, 2022
Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Cyrille Delpierre, et al.
British Journal of Clinical Pharmacology|November 14, 2018
Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT studyMinh P Lê, Marie-Laure Chaix, François Raffi, et al.
AIDS (London, England)|July 18, 2022
Immune recovery-related patterns of post kala-azar dermal and ocular leishmaniasis in people living with HIVStella Rousset, Mathilde Zenou, Aurélie Saunier, et al.
Journal of the International AIDS Society|April 26, 2020
Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV-1 infection: results from a longitudinal study in the French ANRS Primo cohortSophie Novelli, Pierre Delobel, Olivier Bouchaud, et al.
Medicine|September 16, 2016
Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort StudyPaul de Boissieu, Moustapha Dramé, François Raffi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 19, 2012
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 studyLise Cuzin, Selma Trabelsi, Pierre Delobel, et al.
The Journal of Infectious Diseases|November 19, 2024
Compartmentalized Human Immunodeficiency Virus Type 1 Reservoir in Intestinal Monocytes/Macrophages on Antiretroviral TherapyCamille Vellas, Dorine Martres, Mary Requena, et al.
Pageof 16